Nuvectra to Present at Two Upcoming Investor Confe

PLANO, Texas, May 17, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR ), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief Operating Officer & Chief Financial Officer, are scheduled to present at two upcoming investor conferences in June 2018.

A webcast of each presentation will be available by visiting the investor relations section of Nuvectra’s website at www.nuvectramed.com. A webcast replay of the presentation will be available for 90 days.

Investors attending the conference who would like to schedule a one-on-one meeting with Nuvectra management may do so by contacting their Jefferies or JMP Securities representative, or Brian Johnston of The Ruth Group at bjohnston@theruthgroup.com. 

About Nuvectra Corporation

Nuvectra ^TM is a neurostimulation company committed to helping physicians improve the lives of people with chronic conditions. The Algovita ^® Spinal Cord Stimulation (SCS) System is our first commercial offering and is CE marked and FDA approved for the treatment of chronic intractable pain of the trunk and/or limbs. Our innovative technology platform also has capabilities under development to support other indications such as sacral neuromodulation (SNM) for the treatment of overactive bladder, and deep brain stimulation (DBS) for the treatment of Parkinson’s Disease. In addition, our NeuroNexus subsidiary designs, manufactures and markets leading-edge neural-interface technologies for the neuroscience clinical research market. Visit the Nuvectra website at www.nuvectramed.com .